Transdermal methimazole treatment in cats with hyperthyroidism

Journal of Feline Medicine and Surgery

Volumn 5, Issue 2, 2003, Pages 77-82

  Hoffman, G ^a,c   Marks, S L ^a,d   Taboada, J ^a   Hosgood, G L ^a   Wolfsheimer, K J ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Endocrine Diagnostics/Consultation   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; DRUG VEHICLE; IOPODIC ACID; PHOSPHATIDYLCHOLINE; THIAMAZOLE; THYROXINE;

ANOREXIA; ARTICLE; CAT DISEASE; CHRONIC KIDNEY FAILURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG RESPONSE; EXTERNAL EAR; FACE DISORDER; HEMATOLOGIC DISEASE; HYPERTHYROIDISM; LABORATORY TEST; LETHARGY; LIVER TOXICITY; NONHUMAN; RETROSPECTIVE STUDY; THYROXINE BLOOD LEVEL; VOMITING;

FELIS CATUS; PINNA;

EID: 0037377363     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-612X(02)00095-5     Document Type: Article

References (16)

1. Arndt KA, Mendenhall PV, Sloan KB et al (1993) The pharmacology of topical therapy. In: Fitzpatrick TB, Eisen AZ, Wolff K et al (eds) (4th edition) Dermatology in General Medicine. Volume 2: McGraw-Hill, Inc, pp. 2837-2846.
2. Becker TJ, Graves TK, Kruger JM, Braselton WE, Nachreiner RF (2000) Effects of methimazole on renal function in cats with hyperthyroidism. Journal of the American Animal Hospital Association 36, 215-223.
3. Bos JD, Meinardi M (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology 9, 165-169.
4. DiBartola SP, Broome MR, Stein BS, Nixon M (1996) Effect of treatment of hyperthyroidism on renal function in cats. Journal of the American Veterinary Medical Association 208(6), 875-878.
5. Feldman EC, Nelson RW (1996) Feline Hyperthyroidism. In: Canine and Feline Endocrinology and Reproduction (2nd edn). Philadelphia: WB Saunders, pp. 118-165.
6. Goldsmith LA (1991) Physiology, Biochemistry, and Molecular Biology of the Skin (2nd edn). Philadelphia: Oxford University Press, pp. 1447-1479.
7. Goodman LS, Limbird LE, Milinoff P (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th edn). Philadelphia: McGraw Hill Text, pp. 1383-1409.
8. Hoffman SB, Trepanier LA, Kroll M (2001) Evaluation of dosing regimen in hyperthyroid cats with methimazole. Journal of Veterinary Internal Medicine 15(3), 299.
9. Luisi PL, Giomini M, Pileni MP, Robinson BH (1988) Reverse micelles as host for proteins and small molecules. Biochimica et Biophysica Acta 947(1), 209-946.
10. Peterson ME, Graves TK, Cavanagh I (1987) Serum thyroid hormone concentrations fluctuate in cats with hyperthyroidism. Journal of Veterinary Internal Medicine 1(3), 142-146.
11. Peterson ME, Kintzer PP, Hurvitz AI (1988) Methimazole treatment of 262 cats with hyperthyroidism. Journal of Veterinary Internal Medicine 2(3), 150-157.
12. Product information: Tapazole®. Indianapolis, IN, Eli Lilly (1998).
13. Retsios E (2001) Methimazole. Compendium on Continuing Education for the Practicing Veterinarian 23(1), 36-41.
14. Scartazzini R, Luisi PL (1988) Organogels from lecithins. Journal of Physical Chemistry 92(3), 829-833.
15. Trepanier LA, Peterson ME, Aucoin DP (1991) Pharmacokinetics of methimazole in normal cats and cats with hyperthyroidism. Research in Veterinary Science 50, 69-74.
16. Willimann K, Walde P, Luisi PL, Gazzaniga A, Stroppolo F (1992) Lecithin Organogel as Matrix for Transdermal Transport of Drugs. Journal of Pharmaceutical Sciences 81(9), 871-874.